TUGI - The world's easiest applicators

The TUGI project emerged from a friend's personal battle with multiple sclerosis. Witnessing her struggle with stressful and painful injections prompted us to take action. We set out to create a new, patient-centered applicator that addresses the challenges faced by self-injection patients: pain, stress, discomfort, and the difficulty of administering injections oneself. Our solution? A revolutionary applicator designed with patient needs in mind. It offers safety, easy handling, user-friendly features, a welcoming appearance, and high-quality materials. After three years of development, we proudly introduced TUGI Model 1—an applicator for multiple sclerosis, hormone therapy, and IVF treatments. Its target audience? Millions of users seeking a better self-injection experience. Not stopping there, a year later, we unveiled TUGI Model 2—an applicator designed to simplify the treatment and prevention of thrombosis. Compatible with the two most common heparin syringes, this applicator has the potential to aid hundreds of millions of users annually. To validate our success, we conducted independent qualitative research through KANTAR, the world's leading research company. The results were highly promising, as both patients and healthcare professionals confirmed the emotional and functional benefits of the TUGI applicators. In fact, based on KANTAR's international standards, our applicators received the highest possible rating for their meaningful and distinctive impact. TUGI® helps patients who inject themselves with pre-filled syringes into subcutaneous fat: patients with blood clotting problems (low molecular weight heparin (LMWH) users), patients with multiple sclerosis (MS), hormone therapy patients undergoing assisted reproduction treatment (IVF), users of monoclonal antibodies, etc.